ALDH1A3 and neoplasm: We assessed a cohort of 78 archived fixed primary, treatment naïve, human breast tumour samples for co‐expression between ALDH1A3 and tPA, uPA, and PAI‐2 (Table S3, tumour pathology and clinical details summarized).